We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
National Cancer Institute Director Norman “Ned” Sharpless will serve as acting commissioner of the FDA following Scott Gottlieb’s departure next month. Read More
A False Claims Act suit claiming pharmacies Walgreens purchased in 2012 overcharged Medicaid for generic drugs must proceed, according to an Oklahoma federal judge. Read More
The FDA is one of the few government agencies that would get a bump in federal spending under the Trump administration’s proposed fiscal 2020 budget unveiled on Monday. Read More
Three drugmakers urged the U.S. Supreme Court not to review a lower court’s decision on the controversial patent deal between Allergan and the St. Regis Mohawk tribe. Read More